Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2003
11/19/2003EP1060190B1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0967997B1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
11/19/2003EP0914111B1 Prevention and treatment of cachexia and anorexia
11/19/2003EP0912106B1 Agent for increasing the production of/in breeding and production mammals
11/19/2003EP0884052B1 Cartilage/bone inducing materials for reparation
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0766559B1 Cannabinoid receptor antagonists
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1457255A Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
11/19/2003CN1456560A 1-aryl beta-carboline and thio-similities, their preparations and uses in medicines
11/19/2003CN1456349A Biological preparation containing marine active substance and use thereof
11/19/2003CN1456321A Wild jujube kernel tea lozenge and producing method thereof
11/19/2003CN1456280A Process for treating Pengze fritillary bulb and preparing capsules
11/19/2003CN1456219A Ginger carminative oral lozenge
11/19/2003CN1456211A Medicine for curing pectoralgia
11/19/2003CN1456185A Anti-senility Chinese medicine preparation
11/19/2003CN1456174A Anti-anoxia anti-fatigue biological preparation for improving human
11/19/2003CN1456168A Anti-fatigue formulating prescription
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128144C Indane-1-alcohol compound, its preparation method and medical composition containing same
11/19/2003CN1128142C Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
11/19/2003CN1127984C Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
11/19/2003CN1127983C Inmunization adjusting anti-inflamation agent
11/19/2003CN1127962C Capsule for curing hydrocephalus and its producing method
11/18/2003US6649737 Human galactosyltranferases
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649651 AIDS; human T-cell lymphoma/leukemia virus or lymphadenopathy associated virus treatment
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649626 Stimulants of gamma -aminobutyric acid receptors; psychological disorders
11/18/2003US6649625 Agent for prophylaxis and treatment of glaucoma
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649619 Compounds
11/18/2003US6649617 Treatment for stroke management
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649591 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649389 Peptide for use in the diagnosis and treatment of cancer, thyroid, diabetes, atherosclerosis, and cardiovascular disorders
11/18/2003US6649366 Methods and compositions related to modulators of annexin and cartilage homeostasis
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/18/2003US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/18/2003CA2265508C Bone morphogenetic protein-16 (bmp-16) compositions
11/18/2003CA2264155C N6 heterocyclic substituted adenosine derivatives
11/18/2003CA2127472C New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
11/18/2003CA2072233C Triazolopyrimidine derivatives which are angiotensin ii receptor antagonists; processes for preparing them and pharmaceutical compositions containing them
11/13/2003WO2003093793A2 Binary or polynary targeting and uses thereof
11/13/2003WO2003093456A1 Soya cell strains with high isoflavone content
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093409A2 Promoters exhibiting endothelial cell specificity and methods of using same
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093299A2 Insulin-associated peptides with effects on cerebral health
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093292A1 17α-FLUOROALKYL-11β-BENZALDOXIME-STEROIDS, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAID STEROIDS AND THE USE THEREOF IN THE PRODUCTION OF MEDICAMENTS
11/13/2003WO2003093289A1 Tricyclic macrolide antibacterial compounds
11/13/2003WO2003093280A1 Heterotricyclyl 6-alkylidene-penems as βετα-lactamase inhibitors
11/13/2003WO2003093279A1 BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
11/13/2003WO2003093263A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003WO2003093260A1 Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical compositions containing the novel forms and methods for treating nausea using them
11/13/2003WO2003093249A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093241A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093238A1 Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092725A1 Method for control of depression using c terminal growth hormone (gh) fragment
11/13/2003WO2003092720A1 A combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
11/13/2003WO2003092709A1 Method for producing preparations rich in tocotrienol
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092693A1 Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
11/13/2003WO2003092691A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092684A1 TIME-RESOLVED FLUORESCENCE ASSAY FOR THE DETECTION OF MULTIMERIC FORMS OF A-β[BETA] OR OTHER AGGREGATING POLYPEPTIDES
11/13/2003WO2003092681A1 Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1h-[1,2,4]-triazole for the treatment of autoimmune diseases
11/13/2003WO2003092667A1 Composition for treating cancer containing n,n-dimethylphytosphingosine
11/13/2003WO2003092666A1 Calcium-containing tissue strengthening agents and use thereof
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092613A2 Catechin multimers as therapeutic drug delivery agents
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
1 ... 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 ... 1564